Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Cornerstone Therapeutics, a specialty pharmaceutical company focused on developing, acquiring and commercializing products for the respiratory, hospital and related specialty markets, has appointed Kenneth McBean as new president.
Subscribe to our email newsletter
McBean served at Covidien’s Specialty Pharmaceuticals as vice president and general manager from March 2009 until May 2011 and was responsible for executing a successful turnaround of the company’s branded pharmaceutical products division.
He co-founded and headed commercial and corporate development for a number of Canadian-based pharmaceutical start-ups.
At Biovail Pharmaceuticals and DJ Pharma he served as a vice president of Marketing and Commercial Development.
Cornerstone Therapeutics chairman and CEO Craig Collard said Ken’s experience in specialty markets will enhance their ability to grow core products and to acquire and commercialize new products.